Table 3. Potential for the two- and three-condition experimental design to detect relationships between placebo and experimental conditions, and true baseline values. Data are means (±1 SD).
RMS Comparison
Time Period
vhip (cm·s-1)
ωankle (°·s-1)
WR2W-RMSmin
1-20
6.0 (1.8)
37.0 (12.0)
20-40
6.1 (3.0)
22.5 (7.7)
40-60
3.3 (1.4)
30.3 (12.6)
60-80
5.0 (1.7)
41.5 (24.4)
80-100
4.5 (1.4)
26.1 (21.5)
WR2R-RMSmin
1-20
5.0 (2.5)
21.2 (11.1)
20-40
5.6 (2.4)
31.3 (9.8)
40-60
6.0 (2.5)
27.5 (10.5)
60-80
7.6 (3.8)
28.3 (7.8)
80-100
4.9 (2.5)
19.6 (8.4)
WR2W-RMSmin
1-20
3.1 (1.9)
19.5 (11.3)
20-40
3.2 (1.7)
12.3 (9.4)
40-60
3.9 (2.2)
22.4 (12.3)
60-80
6.7 (4.9)
44.0 (20.6)
80-100
8.7 (4.2) *
30.5 (14.1)
WR2R-RMSmin
1-20
44.6 (11.1) †
76.1 (40.5) †
20-40
33.3 (7.6) †
153.9 (45.8) †
40-60
31.4 (8.6) †
148.2 (43.8) †
60-80
19.7 (7.7) †
123.8 (56.5) †
80-100
15.1 (12.3) †
45.0 (9.2) †
* Value is significantly greater than W-RMS (p < 0.05).
† Value is significantly greater than R-RMS (p < 0.05).